Modafinil and Exercise for Post Stroke Fatigue
NCT06354985 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 212
Last updated 2025-06-10
Summary
A stroke happens when blood flow to the brain is stopped and the brain gets damaged. At least half of people with a stroke have fatigue months and even years later. A lot of people report fatigue as one of the worst symptoms post stroke that can affect daily activities and the length and quality of life. Though all the reasons for fatigue after stroke and how to best treat it are not fully understood, the investigators think that fatigue results from the stroke changing the brain, reducing physical fitness, and decreasing muscle strength. A stroke can also affect sleep and mood, which can impact how people feel too. It is also not known why women experience more fatigue than men after a stroke.
Some studies have tested a drug called Modafinil for post stroke fatigue, while other studies have tested exercise for it. Yet, there is unclear evidence for either treatment, so this study has the following aim:
1\. Test if Exercise plus Modafinil is better than Exercise plus a Sugar Pill
This study will take place at up to 6 Canadian research sites to give a good representation of people after a stroke. Each person will be tested on fatigue, mood, fitness, thinking skills, sleep, and usual activity levels.
Participants will be assigned at random (like flipping a coin) to 1 of 2 groups:
1. Sugar Pill plus Exercise
2. Modafinil plus Exercise
The treatment will last 8 weeks. The Modafinil or Sugar Pill will be taken once a day. The exercise will be delivered virtually by a trained therapist over computer to people at home 3 times a week. Change in fatigue, quality of life, and other outcomes will be measured over 6 months.
The investigators will assess the results to identify the best treatment for post stroke fatigue and hope to be able to find a treatment that will help reduce fatigue and improve quality of life after a stroke.
Conditions
Interventions
- DRUG
-
Modafinil 200mg
Modafinil 200mg daily for 8 weeks.
- DRUG
-
Placebo daily for 8 weeks.
- BEHAVIORAL
-
Exercise
Exercise three times per week for 8 weeks.
Sponsors & Collaborators
-
University Health Network, Toronto
lead OTHER
Principal Investigators
-
Mark Bayley, MD, FRCPC · University Health Network, Toronto
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-30
- Primary Completion
- 2027-09-30
- Completion
- 2027-09-30
More Related Trials
-
Inflammation and Post-Stroke Depression
NCT02368145 ·Status: UNKNOWN
-
Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke
NCT06049498 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Impact of Chewing Food on Stroke Patients
NCT06637033 ·Status: COMPLETED ·Phase: NA
-
Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke
NCT03296618 ·Status: UNKNOWN ·Phase: PHASE1
-
Nut Supplementation to Mitigate Post-stroke Cognitive Decline
NCT05902767 ·Status: SUSPENDED ·Phase: NA
-
Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER)
NCT05976152 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Effectiveness of Nutritional Counseling in Patients After Stroke
NCT01517542 ·Status: WITHDRAWN ·Phase: NA
-
Melatonin for Prevention of Post Stroke Delirium
NCT04122599 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Melatonin in Acute Stroke
NCT03843008 ·Status: WITHDRAWN ·Phase: NA
-
The Study in the Correlation Between the Severity of Post-stroke Fatigue and the Severity of qi Deficiency and Blood Stasis
NCT01669759 ·Status: UNKNOWN
-
Cerebroprotective Effect of Melatonin in Stroke
NCT05857046 ·Status: RECRUITING ·Phase: PHASE3
-
Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke
NCT01623622 ·Status: COMPLETED ·Phase: PHASE2
-
Acupuncture for Ischemic Post-stroke Depression
NCT02472613 ·Status: COMPLETED ·Phase: NA
-
Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage
NCT04857632 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Post-stroke Depression Treatment Effect on Stroke Recurrence
NCT04776226 ·Status: COMPLETED ·Phase: NA
-
COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)
NCT06062277 ·Status: UNKNOWN ·Phase: PHASE2
-
Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania
NCT03728153 ·Status: COMPLETED ·Phase: PHASE2
-
FMRI in Monitoring Intracerebral Stem Cell Implantation for Chronic Stroke Patients
NCT01249287 ·Status: UNKNOWN
-
Stroke and Tocotrienol: Unique Role in Neuroprotection
NCT02263924 ·Status: UNKNOWN ·Phase: PHASE3
-
Relationship of Nocturnal Concentrations of Melatonin, γ-aminobutyric Acid and Total Antioxidants With Insomnia
NCT03202121 ·Status: UNKNOWN
-
Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke Epilepsy
NCT05987397 ·Status: RECRUITING ·Phase: PHASE4
-
Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
NCT04200781 ·Status: UNKNOWN ·Phase: PHASE4
-
Multi-"Omics" Research of Danhong Injection to Treat Acute Ischemic Stroke
NCT02176395 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment
NCT07220538 ·Status: RECRUITING ·Phase: PHASE4
-
Dynamic Combination Therapy on Chinese Herbal Granules to Improve the Symptoms in Convalescent Phase of Ischemic Stroke
NCT01780480 ·Status: COMPLETED ·Phase: NA